Necrolytic acral erythema
Necrolytic acral erythema (NAE) is a skin condition that can accompany hepatitis C infection or zinc deficiency. It usually shows up as red-to-dark plaques on the tops of the feet and toes, and sometimes on other parts of the body.
Signs and symptoms
- Early: flaccid blisters, erosions, and red-to-violaceous papules at the edges of the lesions.
- Later: well-defined, thick, scaly plaques with a dark border (hyperkeratotic plaques); surrounding skin may be red and swollen.
- Common and other areas: commonly affects the dorsum of the feet and toes; can involve ankles, legs, knees, and occasionally the buttocks, genitals, hands, and elbows. Nails, palms, and soles may also be affected.
- Course: lesions can be acute or chronic and may come and go over months to years.
Causes and pathophysiology
- The exact cause is unknown and likely multifactorial.
- The condition is linked to hepatitis C infection and zinc deficiency, but other metabolic factors (such as liver dysfunction, low amino acids, low albumin, and diabetes) may play a role.
Diagnosis
- Based on appearance and a skin biopsy.
- Early stage: epidermal necrosis with blisters, spongiosis, and acanthosis.
- Well-developed stage: necrotic keratinocytes, psoriasiform hyperplasia, subcorneal pustules, papillomatosis, and parakeratosis.
- Some cases may not show the classic histology.
Treatment and prognosis
- The most effective treatment to date is oral zinc supplementation.
- Addressing any underlying hepatitis C infection and correcting zinc deficiency are important.
- Lesions may improve with treatment, but relapses can occur.
Epidemiology
- Affects males and females about equally.
- Typical age range is 19–58 years, with a mean around 44 years and a median near 50.
See also
- Necrolytic migratory erythema (related skin condition)
- List of cutaneous conditions
This summarizes what necrolytic acral erythema is, how it presents, what might cause it, how it’s diagnosed, and how it’s treated.
This page was last edited on 1 February 2026, at 22:01 (CET).